» Articles » PMID: 25401953

A Retrospective Investigation on Canine Papillomavirus 1 (CPV1) in Oral Oncogenesis Reveals Dogs Are Not a Suitable Animal Model for High-risk HPV-induced Oral Cancer

Overview
Journal PLoS One
Date 2014 Nov 18
PMID 25401953
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

CPV1 (also called COPV) is a papillomavirus responsible for oral papillomatosis in young dogs. The involvement of this viral type in oral oncogenesis has been hypothesized in oral squamous cell carcinomas (SCCs), but has never been investigated in other neoplastic and hyperplastic oral lesions of dogs. Aim of this study was to investigate the presence of CPV1 in different neoplastic and hyperplastic lesions in order to assess its role in canine oral oncogenesis; according to the results obtained, a second aim of the study was to define if the dog can be considered a valid animal model for oral high risk HPV-induced tumors. Eighty-eight formalin-fixed, paraffin-embedded (FFPE) canine oral lesions including 78 oral tumors (papillomas, SCCs, melanomas, ameloblastomas, oral adenocarcinomas) and 10 hyperplastic lesions (gingival hyperplasia) were investigated with immunohistochemistry for the presence of papillomavirus L1 protein and with Real-Time PCR for CPV1 DNA. RT-PCR for RNA was performed on selected samples. All viral papillomas tested were positive for immunohistochemistry and Real-time PCR. In 3/33 (10%) SCCs, viral DNA was demonstrated but no viral RNA could be found. No positivity was observed both with immunohistochemistry and Real-Time PCR in the other hyperplastic and neoplastic lesions of the oral cavity of dogs. Even though the finding of CPV1 DNA in few SCCs in face of a negative immunohistochemistry could support the hypothesis of an abortive infection in the development of these lesions, the absence of viral RNA points out that CPV1 more likely represents an innocent bystander in SCC oncogenesis. The study demonstrates a strong association between CPV1 and oral viral papillomas whereas viral contribution to the pathogenesis of other oral lesions seems unlikely. Moreover, it suggests that a canine model of CPV1 infection for HPV-induced oncogenesis could be inappropriate.

Citing Articles

Papillomaviruses and Papillomaviral Disease in Dogs and Cats: A Comprehensive Review.

Munday J, Knight C Pathogens. 2025; 13(12.

PMID: 39770317 PMC: 11728566. DOI: 10.3390/pathogens13121057.


Cell proliferation and apoptosis in canine oral papillomatosis.

Karakurt E, Coskun N, Aydin U, Dag S, Beytut E, Ataseven V Vet Res Forum. 2024; 15(2):75-82.

PMID: 38465317 PMC: 10924297. DOI: 10.30466/vrf.2023.1996086.3818.


Exploring animal models in oral cancer research and clinical intervention: A critical review.

Khayatan D, Hussain A, Tebyaniyan H Vet Med Sci. 2023; 9(4):1833-1847.

PMID: 37196179 PMC: 10357283. DOI: 10.1002/vms3.1161.


Papillomaviral skin diseases of humans, dogs, cats and horses: A comparative review. Part 2: Pre-neoplastic and neoplastic diseases.

Munday J, Knight C, Luff J Vet J. 2022; 288:105898.

PMID: 36152994 PMC: 11459685. DOI: 10.1016/j.tvjl.2022.105898.


New insights into Canis familiaris papillomaviruses genetics and biology: Is the genetic characterization of CPV types and their variants an important clinical issue?.

Reis J, Batista M Genet Mol Biol. 2022; 45(3 Suppl 1):e20210388.

PMID: 36095300 PMC: 9469487. DOI: 10.1590/1678-4685-GMB-2021-0388.


References
1.
Stanley M, Moore R, Nicholls P, Santos E, Thomsen L, Parry N . Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs. Vaccine. 2001; 19(20-22):2783-92. DOI: 10.1016/s0264-410x(00)00533-8. View

2.
Kansy K, Thiele O, Freier K . The role of human papillomavirus in oral squamous cell carcinoma: myth and reality. Oral Maxillofac Surg. 2012; 18(2):165-72. DOI: 10.1007/s10006-012-0383-0. View

3.
Nicholls P, Moore P, Anderson D, Moore R, Parry N, Gough G . Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes. Virology. 2001; 283(1):31-9. DOI: 10.1006/viro.2000.0789. View

4.
Zur Hausen H . Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002; 2(5):342-50. DOI: 10.1038/nrc798. View

5.
Campo M . Animal models of papillomavirus pathogenesis. Virus Res. 2002; 89(2):249-61. DOI: 10.1016/s0168-1702(02)00193-4. View